Inhibitor for perioperative blood sugar elevation
AssigneeOtsuka Pharmaceutical Factory, Inc.
InventorsIppei Yamaoka, Yasuhiro Mitsumoto, Masako Doi, Tetsuya Fukunaga, Mitsuo Nakayama
Life of this patent
Estimating the term…
Abstract
An inhibitor for perioperative blood sugar elevation characterized by containing a branched amino acid, a compound which can be converted into a branched amino acid in vivo or a compound to which an amino group has been transferred from a branched amino acid. This inhibitor for perioperative blood sugar elevation is useful as a drug which is safe to the living body including human, inhibits abnormal elevation in the blood glucose level caused by anesthesia, surgery, etc., and enables proper blood sugar control, when administered to a perioperative patient.
Claims2
A method of inhibiting blood sugar elevation caused by an anesthetic agent administered to a perioperative patient under fasting condition, which comprises administering an inhibitor for blood sugar elevation consisting essentially of isoleucine, to the perioperative patient under fasting condition, wherein the inhibitor for blood sugar elevation contains 0.25 to 3.5 g/dL of isoleucine.
Dependencies are inferred from the claim text.